N
Ning Li
Researcher at Zhengzhou University
Publications - 53
Citations - 374
Ning Li is an academic researcher from Zhengzhou University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 8, co-authored 29 publications receiving 215 citations.
Papers
More filters
Journal ArticleDOI
Prognostic evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin expression in gastric cancer
TL;DR: Evidence is provided that combined evaluation of Nanog, Oct4, Sox2, PCNA, Ki67 and E-cadherin may be a more powerful prognostic factor to predict relapse and distant metastasis for patients with GC.
Journal ArticleDOI
Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway.
Dan Li,Gangcheng Wang,Guoguo Jin,Ke Yao,Zhenjiang Zhao,Liangyu Bie,Yongjun Guo,Ning Li,Wenying Deng,Xiaobin Chen,Beibei Chen,Yuanyuan Liu,Suxia Luo,Zhiping Guo +13 more
TL;DR: The present study demonstrated that resveratrol inhibited cell proliferation and colony growth in DLD1 and HCT15 colon cancer cells, but did not affect normal colon epithelial cells, and suggested that the targeting effects of resver atrol to AKT1 and AKT2 may be a potent strategy for chemoprevention or therapy for colon cancer.
Journal ArticleDOI
Relationships among KRAS mutation status, expression of RAS pathway signaling molecules, and clinicopathological features and prognosis of patients with colorectal cancer
Xiangbin Wan,Ai-Qin Wang,Jian Cao,Zhi-Chuang Dong,Ning Li,Sen Yang,Miao-Miao Sun,Zhi Li,Suxia Luo +8 more
TL;DR: KRAS gene mutations do not affect downstream protein expression in CRC, and KRAS protein is associated with poor tumor differentiation, older age, and a risk of tumor recurrence.
Journal ArticleDOI
LncRNA MCF2L-AS1 aggravates proliferation, invasion and glycolysis of colorectal cancer cells via the crosstalk with miR-874-3p/FOXM1 signaling axis
Zhandong Zhang,Wei Yang,Ning Li,Xiaobin Chen,Fei Ma,Jian Yang,Yonglei Zhang,XiaoFei Chai,Bin Zhang,Xinfang Hou,Suxia Luo,Yawei Hua +11 more
TL;DR: It is highlighted that MCF2L-AS1 acted as a motivator by modulating the miR-874-3p/FOXM1 axis, thereby aggravating tumorigenesis and glycolysis progress of CRC, disclosing that MCf2L -AS1 may serve as a valuable and promising therapeutic strategy for CRC.
Journal ArticleDOI
Lymph Node Ratio as an Alternative to the Number of Metastatic Lymph Nodes for the Prediction of Esophageal Carcinoma Patient Survival.
TL;DR: LNR has greater prognostic value than pN for esophageal squamous cell carcinoma, especially for patients with <12 LNs removed, and among the three significant variables verified by multivariate analyses, LNR was the best for inadequately staged patients (<12 examined LNs.